+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Variability in shiga toxin binding and P-K blood group expression in individual platelet donors



Variability in shiga toxin binding and P-K blood group expression in individual platelet donors



Transfusion 35(10 Suppl. ): 18S




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034181642

Download citation: RISBibTeXText


Related references

A mutant Shiga-like toxin IIe bound to its receptor Gb3: Structure of a group II Shiga-like toxin with altered binding specificity. Structure 8(3): 253-264, March 15, 2000

Shiga toxin binding correlates with P1 blood group antigen in human endothelial cells and erythrocytes. Abstracts of the General Meeting of the American Society for Microbiology 101: 93, 2001

Shiga toxin binding correlates with P1 blood group antigen in human adult and cord erythrocytes. Glycobiology 11(10): 903, 2001

Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2. Journal of Infectious Diseases 201(7): 1081-1083, 2010

Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis. Journal of Bacteriology 172(2): 653-658, 1990

Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor. Journal of Clinical Microbiology 27(6): 1145-1150, 1989

Quantitation and localization of shiga toxin/shiga-like toxin-binding glycolipid receptors in human and baboon tissues. Karmali, M A, Goglio, A G International Congress Series; Recent advances in verocytotoxin producing Escherichia coli infections 189-195, 1994

Inhibition of elongation factor 1 dependent aminoacyl transfer rna binding to ribosomes by shiga like toxin i vt1 from escherichia coli o157 h7 and by shiga toxin. FEMS Microbiology Letters 44(1): 91-94, 1987

The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagnostic Microbiology and Infectious Disease 59(3): 235-242, 2007

Influence of the culture parameters on growth and Shiga toxin expression of Shiga-toxin producing Escherichia coli (STEC). Zycie Weterynaryjne 82(9): 756-762, 2007

Hybridization of Escherichia coli producing Shiga-like toxin I, Shiga-like toxin II, and a variant of Shiga-like toxin II with synthetic oligonucleotide probes. Infection and Immunity 57(9): 2811-2814, 1989

Combined use of demonstration of Shiga toxin in enrichment culture and enterohemolyin on washed sheep blood agar for the isolation of non-O157H7/- Shiga toxin-producing Escherichia coli. Abstracts of the General Meeting of the American Society for Microbiology 101: 186, 2001

Effects of fosfomycin on Shiga toxin-producing Escherichia coli: quantification of copy numbers of Shiga toxin-encoding genes and their expression levels using real-time PCR. Journal of Medical Microbiology 58(Pt 7): 971-973, 2009

The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of. 2007

Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes. Nephrology, Dialysis, Transplantation 22(3): 749-755, 2006